Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-002921
Filing Date
2025-04-07
Accepted
2025-04-07 07:50:30
Documents
1
Period of Report
2025-04-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3115
  Complete submission text file 0001641172-25-002921.txt   4549
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Issuer) CIK: 0001799788 (see all company filings)

EIN.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GREENWICH LIFESCIENCES, INC. 3992 BLUEBONNET DR., BUILDING 14 STAFFORD TX 77477
Business Address
Patel Snehal (Reporting) CIK: 0001806920 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39555 | Film No.: 25816378